Publication: Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity
11
item.page.dc.date.issued
1986-12-01
item.page.dc.type
item.page.dc.identifier.issn
01252208
item.page.dc.identifier.other
2-s2.0-0022885575
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Journal of the Medical Association of Thailand. Vol.69, No.SUPPL. 2 (1986), 56-61
punsarn.item.page.citation
P. B. Isarangkura, P. Bintadish, A. Tejavej, P. Siripoonya, R. Chulajata, G. M. Green, K. Chalermchandra Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity. Journal of the Medical Association of Thailand. Vol.69, No.SUPPL. 2 (1986), 56-61. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/9790
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Vitamin K in oral drops and intramuscular injection given at birth to Thai infants were compared to determine whether these routes and doses would influence prothrombin complex activity, mortality or morbidity at 0.5, 1 and 2 months of age. The infants were 321 normal fullterm babies born at Bangkok Adventist Hospital in 1983, exclusively breastfed during the study. Prothrombin complex (PC) was measured by the Owren capillary thrombotest method using a reagent from Nyegaard Co., Oslo. Vitamin K was given in single 1 or 2 mg oral doses, or 1 mg im, within 12 hours of delivery. Judging by the number of PC deficient children, the 1 mg im and 2 mg oral doses of vitamin K maintained clotting factors best at 2 months of age. All formulations were significantly better than no treatment at 1 month at age. No toxicity or side effects were seen. Vitamin K deficiency is a known cause of bleeding disorders, particularly fatal and handicapping intracranial hemorrhage in newborns, in developing countries where injections cannot be given by midwives. These inexpensive oral pediatric drops may provide a practical form of primary health care for routine vitamin K prophylaxis in newborns.